Alternative splicing Cardiomyopathy Allele-specific silencing Cancer biomarkers Laminopathie Cardiology Skeletal muscle Becker muscular dystrophy Nuclear envelope Myopathies COL1A1 Congenital muscular dystrophy GNE Treatment BVES Exome CRISPR Myotubes Angiotensin-converting enzyme inhibitor Treatment delay Calcium handling Duchenne muscular dystrophy IPSC Emerin Muscle Errance diagnostique Centronuclear myopathy Emery-Dreifuss muscular dystrophy Laminopathy Lamin A/C nuclei Laminopathies Mouse Therapy Mutations LGMD Ehlers‐Danlos Syndrome Neuromuscular diseases AAV VECTOR Cardiac conduction system Heart Connective tissue POPDC1 RNA interference Biological sciences A-type lamins LMNA Muscle biopsy INPP5K C elegans COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Lamins Muscular dystrophy MD Dystrophine COL6A1 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Patient registry Cancer Actionable gene CSF protein Acetyltransferase C2C12 Heart failure Allele-specific silencing therapy Allele‐specific silencing therapy Biomarker Muscle MRI Next generation sequencing Dilated cardiomyopathy Diagnosis Hypermobile EDS Myogenesis Rare neuromuscular diseases Regeneration Myologie Actionability Butyrylcholinesterase Autophagosome maturation Base de données FAIR AAV Maladies rares Myopathy LMNA-related congenital muscular dystrophy A-type lamin Dynamin 2 Adult SMA Rare diseases Lamin A/C LMNA gene COVID-19 Angiotensin-converting enzyme inhibitors CMTX Titin Clinical trial LMNA gene Joint laxity Maladies rares et orphelines Lamin A/C Muscular dystrophy Dystrophie musculaire Gene therapy BiP